ScreenerHero
RAY-BRaySearch Laboratories AB (publ)
STO · SE · Healthcare · Health Information Services · raysearchlabs.com
183.40SEK+1.21%Mkt Cap: 522.84M $P/E: 29.44

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology infor…

Industry Peers

Health Information Services
Screen all
VEE
Veeva System Inc. R
$38.07BUSDP/E 44.2
VEEV
Veeva Systems Inc Class A
$40.77BUSDP/E 44.6
BTSG
BrightSpring Health Services Inc. Common Stock
$11.74BUSDP/E 53.0
TEM
Tempus AI Inc. Class A Common Stock
$11.05BUSD
HQY
HealthEquity, Inc.
$8.71BUSDP/E 38.9
TXG
10x Genomics, Inc.
$8.10BUSD
HNGE
Hinge Health Inc. Class A Common Stock
$7.14BUSDP/E 10.8
WAY
Waystar Holding Corp. Common Stock
$4.76BUSDP/E 35.5
DOCS
Doximity, Inc.
$4.62BUSDP/E 30.9
HTFL
Heartflow Inc. Common Stock
$3.96BUSD
PRVA
Privia Health Group, Inc.
$2.75BUSDP/E 97.7
OMCL
Omnicell, Inc.
$1.66BUSDP/E 43.4
OMDA
Omada Health Inc. Common Stock
$1.50BUSDP/E 36.5
SDGR
Schrödinger, Inc.
$1.48BUSD
CERT
Certara, Inc.
$1.28BUSD
GDRX
GoodRx Holdings, Inc.
$1.21BUSDP/E 59.0
TDOC
Teladoc Health, Inc.
$1.18BUSD
TALK
Talkspace Inc. Common Stock
$870.57MUSD
HSTM
HealthStream, Inc.
$834.80MUSDP/E 39.7
PHR
Phreesia, Inc.
$738.82MUSDP/E 74.8

Key Statistics

Company
Market Cap522.84M $
Enterprise Value596.64M $
Revenue (TTM)121.47M $
Gross Profit118.84M $
Net Income (TTM)21.79M $
Revenue/Share3.552 USD
Last Price183.40 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees464
CountrySE
SectorHealthcare
IndustryHealth Information Services
ISINSE0000135485
Valuation
P/E (Trailing)29.44
P/E (Forward)27.27
PEG25.65
EV/EBITDA18.12
EV/Revenue4.91
P/S4.29
P/B6.02
EPS (TTM)6.23
EPS (Forward)6.71
52W Range
153.1024% of range278.00
52W High278.00 SEK
52W Low153.10 SEK
Profitability
Gross Margin92.42%
Oper. Margin10.32%
EBITDA Margin27.11%
Profit Margin16.95%
ROE23.12%
ROA11.44%
Growth
Revenue Growth-10.70%
Earnings Growth-36.60%
Cash Flow & Leverage
Operating CF37.02M $
CapEx (TTM)21.82M $
FCF Margin10.31%
FCF Yield2.39%
Net Debt13.97M $
Net Debt/EBITDA0.42
Balance Sheet
Debt/Equity0.40
Current Ratio1.29
Quick Ratio1.23
Book Value/Sh30.41 SEK
Cash/Share6.339 SEK
Dividends
Fwd Div Rate4.000 SEK
Trail. Div Rate4.000 SEK
Div. Yield2.19%
5Y Avg Yield—
Payout Ratio64.21%
Ex-Div DateMay 8, 2026
Pay Date—
Splits
Last Split3:1
Split DateJun 25, 2008
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)297.50 SEK
Upside (mean)+62.2%
Target Range250.00 SEK – 345.00 SEK
SEK250.00+62.2% to meanSEK345.00
# Analysts2
Ownership
Shares Out.29.80M
Float27.52M
Insiders10.85%
Institutions55.54%
Technical
SMA 50199.76 (-8.2%)
SMA 200204.03 (-10.1%)
Beta0.92
S&P 52W Chg18.16%
Avg Vol (30d)241.25K
Avg Vol (10d)313.42K
Technical Indicators
RSI (14)43.3
MACD-3.0810
MACD Signal-5.1039
MACD Hist.+2.0229
BB Upper195.83 SEK
BB Middle179.66 SEK
BB Lower163.49 SEK
BB Width18.00%
ATR (14)8.882 SEK
Vol Ratio (20d)0.56x